Adv Pharm Bull. 2018;8(4): 617-625. doi: 10.15171/apb.2018.070
PMID: 30607334        PMCID: PMC6311639

Research Article

Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index

Sachin Kumar 1, Ramneek Kaur 1, Rashi Rajput 1, Manisha Singh 1 * ORCID

Cited by CrossRef: 0

1- Chikukwa M, Walker R, Khamanga S. Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form. Pharmaceutics. 2020;12(8):712 [Crossref]
2- Gupta R, Chen Y, Xie H. In vitro dissolution considerations associated with nano drug delivery systems. WIREs Nanomed Nanobiotechnol. 2021; [Crossref]